Enlivex Therapeutics
ENLV
ENLV
28 hedge funds and large institutions have $940K invested in Enlivex Therapeutics in 2025 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 0 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
67% less capital invested
Capital invested by funds: $2.87M → $940K (-$1.93M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 6
Holders
28
Holding in Top 10
–
Calls
$40K
Puts
$7K
Top Buyers
| 1 | +$241K | |
| 2 | +$71.7K | |
| 3 | +$57K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$44.4K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$35.6K |
Top Sellers
| 1 | -$1.58M | |
| 2 | -$686K | |
| 3 | -$47.3K | |
| 4 |
Jane Street
New York
|
-$41.1K |
| 5 |
Renaissance Technologies
New York
|
-$11.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| $104 |
|
|||
|
ASN
27
Advisory Services Network
Atlanta,
Georgia
| $45 |
|
|||
|
SS
28
SBI Securities
Tokyo,
Japan
| $1 |
|
|||
|
AC
29
Armistice Capital
New York
| – |
|
|||
30
Millennium Management
New York
| – |
|
|||
31
Raymond James Financial
St Petersburg,
Florida
| – |
|